Allogene retains control of cancer therapy after arbitration ruling
Go back to Allogene retains control of cancer therapy after arbitration ruling| (NASDAQ: ALLO) | Delayed: 1.73 -0.13 (6.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.86 | 52 Week High | $ | |||
| Open | $1.85 | 52 Week Low | $ | |||
| Day High | $1.88 | P/E | N/A | |||
| Day Low | $1.72 | EPS | $ | |||
| Volume | 7,281,091 | |||||
| (NASDAQ: CLLS) | Delayed: 3.13 -0.03 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.16 | 52 Week High | $37.55 | |||
| Open | $3.07 | 52 Week Low | $16.35 | |||
| Day High | $3.19 | P/E | N/A | |||
| Day Low | $3.01 | EPS | $0.00 | |||
| Volume | 9,485 | |||||
